Anti-™EM199 monoclonal antibody

Pre-made anti-™EM199 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM199/™EM199 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2034-Ab-1/ GM-Tg-hg-IP2034-Ab-2Anti-Human ™EM199 monoclonal antibodyHuman
GM-Tg-rg-IP2034-Ab-1/ GM-Tg-rg-IP2034-Ab-2Anti-Rat ™EM199 monoclonal antibodyRat
GM-Tg-mg-IP2034-Ab-1/ GM-Tg-mg-IP2034-Ab-2Anti-Mouse ™EM199 monoclonal antibodyMouse
GM-Tg-cynog-IP2034-Ab-1/ GM-Tg-cynog-IP2034-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM199 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2034-Ab-1/ GM-Tg-felg-IP2034-Ab-2Anti-Feline ™EM199 monoclonal antibodyFeline
GM-Tg-cang-IP2034-Ab-1/ GM-Tg-cang-IP2034-Ab-2Anti-Canine ™EM199 monoclonal antibodyCanine
GM-Tg-bovg-IP2034-Ab-1/ GM-Tg-bovg-IP2034-Ab-2Anti-Bovine ™EM199 monoclonal antibodyBovine
GM-Tg-equg-IP2034-Ab-1/ GM-Tg-equg-IP2034-Ab-2Anti-Equine ™EM199 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2034-Ab-1/ GM-Tg-hg-IP2034-Ab-2; GM-Tg-rg-IP2034-Ab-1/ GM-Tg-rg-IP2034-Ab-2;
GM-Tg-mg-IP2034-Ab-1/ GM-Tg-mg-IP2034-Ab-2; GM-Tg-cynog-IP2034-Ab-1/ GM-Tg-cynog-IP2034-Ab-2;
GM-Tg-felg-IP2034-Ab-1/ GM-Tg-felg-IP2034-Ab-2; GM-Tg-cang-IP2034-Ab-1/ GM-Tg-cang-IP2034-Ab-2;
GM-Tg-bovg-IP2034-Ab-1/ GM-Tg-bovg-IP2034-Ab-2; GM-Tg-equg-IP2034-Ab-1/ GM-Tg-equg-IP2034-Ab-2
Products NameAnti-™EM199 monoclonal antibody
Formatmab
Target Name™EM199
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM199 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2034-Ag-1Recombinant multi-species ™199/ ™EM199/ C17orf32 protein


    Target information

    Target IDGM-IP2034
    Target Name™EM199
    Gene ID147007,195040,303332,708298,491163,101101011,511376,100058999
    Gene Symbol and SynonymsC17orf32,CDG2P,™EM199,VMA12,VPH2
    Uniprot AccessionQ8N511,Q5BK13
    Uniprot Entry Name™199_HUMAN,™199_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000244045
    Target ClassificationN/A

    The target: ™EM199, gene name: ™EM199, also named as C17orf32, CDG2P, VMA12, VPH2. The protein encoded by this gene has been observed to localize to the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) and coat protein complex I (COPI) in some human cells. The encoded protein shares some homology with the yeast protein Vma12. Defects in this gene are a cause of congenital disorder of glycosylation, type IIp. [provided by RefSeq, Mar 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.